Health
US Doubles Spending on Potential Covid-19 Vaccine to Nearly $1 Bn, Final Phase of Trials Begins Today – News18
Moderna said the added investment was justified by its decision, in conjunction with the government, to “significantly” expand a Phase Three clinical trial of a candidate vaccine to include 30,000 participants.
The United States has doubled its investment — to nearly $1 billion — to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday begins the decisive final phase of clinical trials.
The government now plans to spend up to $472 million on top of the previously announced $483 million, the Moderna biotechnology company announced Sunday.
Moderna said the added investment was justified by its decision, in conjunction with the government, to “significantly” ex…
Continue Reading